Infuence of the human MIF promoter polymorphism on hepatocellular carcinoma prognosis

Genetics and Molecular Research

Volumn 12, Issue 4, 2013, Pages 6629-6635

  Yuan, T ^a   Tang, C ^a   Chen, M ^a   Deng, S ^a   Chen, P ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; MIF 794CATT; Polymorphism; Promoter

Indexed keywords

MIGRATION INHIBITION FACTOR; ISOMERASE; MACROPHAGE MIGRATION INHIBITION FACTOR; MICROSATELLITE DNA; MIF PROTEIN, HUMAN;

ARTICLE; CANCER PROGNOSIS; CANCER STAGING; GENE SEQUENCE; GENETIC POLYMORPHISM; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; METASTASIS; MICROSATELLITE MARKER; MIF GENE; MOLECULAR PHYLOGENY; PROMOTER REGION; SURVIVAL RATE; SURVIVAL TIME; TUMOR DIFFERENTIATION; TUMOR RECURRENCE; DNA SEQUENCE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; LIVER TUMOR; LYMPH NODE METASTASIS; MORTALITY; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROGNOSIS; SURVIVAL;

BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MICROSATELLITE REPEATS; NEOPLASM RECURRENCE, LOCAL; POLYMORPHISM, GENETIC; PROGNOSIS; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA; SURVIVAL ANALYSIS;

EID: 84887315317     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2013.january.4.3     Document Type: Article

References (18)

1. Arisawa T, Tahara T, Shibata T, Nagasaka M, et al. (2008). Functional promoter polymorphisms of the macrophage migration inhibitory factor gene in gastric carcinogenesis. Oncol. Rep. 19: 223-228.
2. Baugh JA, Chitnis S, Donnelly SC, Monteiro J, et al. (2002). A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun. 3: 170-176.
3. Chesney J, Metz C, Bacher M, Peng T, et al. (1999). An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma. Mol. Med. 5: 181-191.
4. De Benedetti F, Meazza C, Vivarelli M, Rossi F, et al. (2003). Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 48: 1398-1407.
5. Donn R, Alourf Z, De Benedetti F, Meazza C, et al. (2002). Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum. 46: 2402-2409.
6. Donn RP, Plant D, Jury F, Richards HL, et al. (2004). Macrophage migration inhibitory factor gene polymorphism is associated with psoriasis. J. Invest. Dermatol. 123: 484-487.
7. Farinati F, Rinaldi M, Gianni S and Naccarato R (2000). How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system. Cancer 89: 2266-2273.
8. Hira E, Ono T, Dhar DK, El-Assal ON, et al. (2005). Overexpression of macrophage migration inhibitory factor induces angiogenesis and deteriorates prognosis after radical resection for hepatocellular carcinoma. Cancer 103: 588-598.
9. Hudson JD, Shoaibi MA, Maestro R, Carnero A, et al. (1999). A proinfammatory cytokine inhibits p53 tumor suppressor activity. J. Exp. Med. 190: 1375-1382.
10. McDevitt AD, Vega R, Rambau RV, Yannic G, et al. (2011). Colonization of Ireland: revisiting 'the pygmy shrew syndrome' using mitochondrial, Y chromosomal and microsatellite markers. Heredity 107: 548-557.
11. Meyer-Siegler KL, Leifheit EC and Vera PL (2004). Inhibition of macrophage migration inhibitory factor decreases proliferation and cytokine expression in bladder cancer cells. BMC Cancer 4: 34.
12. Meyer-Siegler KL, Vera PL, Iczkowski KA, Bifulco C, et al. (2007). Macrophage migration inhibitory factor (MIF) gene polymorphisms are associated with increased prostate cancer incidence. Genes Immun. 8: 646-652.
13. Mizue Y, Ghani S, Leng L, McDonald C, et al. (2005). Role for macrophage migration inhibitory factor in asthma. Proc. Natl. Acad. Sci. U. S. A. 102: 14410-14415.
14. Nohara H, Okayama N, Inoue N, Koike Y, et al. (2004). Association of the -173 G/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis. J. Gastroenterol. 39: 242-246.
15. Radstake TR, Sweep FC, Welsing P, Franke B, et al. (2005). Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor. Arthritis Rheum. 52: 3020-3029.
16. Seki T, Tamai T, Nakagawa T, Imamura M, et al. (2000). Combination therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation therapy for hepatocellular carcinoma. Cancer 89: 1245-1251.
17. Shimizu T, Abe R, Nakamura H, Ohkawara A, et al. (1999). High expression of macrophage migration inhibitory factor in human melanoma cells and its role in tumor cell growth and angiogenesis. Biochem. Biophys. Res. Commun. 264: 751-758.
18. Wu J, Fu S, Ren X, Jin Y, et al. (2009). Association of MIF promoter polymorphisms with childhood asthma in a northeastern Chinese population. Tissue Antigens 73: 302-306.